世界の空間オーミクス（OMICS）市場規模は2028年までに4億8,422万USドルに達する見込みです。2021年から2028年までのCAGRは10.00%で拡大すると予想されています。COVID-19のパンデミックは、世界の多くの産業を減速させました。しかし、この市場はパンデミックによる広範な悪影響を受けませんでした。
新興企業や既存の企業は、製品開発を継続し、革新的なソリューションを発表して、イノベーターを超えて提供する製品を民主化し、M&Aを行いました。空間オーミクス（OMICS）分野は、ハイパープレックスイメージングに端を発しています。ただし、主要な企業は、空間トランスクリプトミクスソリューションおよび製品の開発にシフトしています。
組織、遺伝子、単一細胞のシークエンスが急速に進歩した結果、空間的なゲノムシークエンスが登場しました。空間オーミクス（OMICS）技術は、定量的な遺伝子発現データを提供し、組織切片内のDNAおよびRNAのマッピングを視覚化します。空間オーミクス（OMICS）のための新技術の開発は、トランスレーショナルリサーチや診断の分野に有益な機会をもたらすことが予想されます。
空間ゲノミクス技術は、新しいプラットフォームの登場により、予測期間中、最も速いCAGRで拡大すると予想されています。トランスクリプトミクス、ゲノミクス、プロテオミクス研究にハイスループットソリューションを導入することで、疾患の発生とゲノム位置の関連性を明らかにすることが可能になりました。
2020年は、空間オーミクス（OMICS）研究のための新しい自動化されたソリューションの発売により、機器製品が第2位のシェアを占めました。例えば、Rebus Biosystems社は2021年3月、組織生物学の理解を深めるための新しい空間オミックスプラットフォーム「Rebus Esper」を発表しました。この新しい統合・自動化された装置は、先進の流体工学、イメージング、化学、バイオインフォマティクスのソリューションを用いて、細胞内の分解能と空間的なコンテクストを備えた定量的な単一細胞・単一分子データを提供します。
予測期間中、新鮮な冷凍サンプルタイプが大きな成長を遂げると予想されています。プロテオミクスにおける新鮮な冷凍サンプルの利点は、いくつかの研究で検証されています。たとえば、2021年3月の研究では、フィルター支援サンプル調製（FASP）技術により、ホルマリン固定パラフィン包埋（FFPE）サンプルよりも新鮮な凍結サンプルを使用することで20％多くのタンパク質同定が得られたと結論付けられました。
北アメリカは、トランスレーショナルリサーチへの関心の高まり、政府によるゲノミクスおよびシーケンシング技術への支援の増加、個別化医療への需要の高まり、トランスレーショナルリサーチおよび学術研究機関の数の多さなどにより、2020年には最大のシェアを獲得しました。
目次
Table of Contents
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.5 Information or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Market Model
1.8 Objectives
1.8.1 Objective 1:
1.8.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Industry Outlook
3.1 Industry Pyramid Analysis
3.1.1 Parent Market Analysis
3.1.2 Ancillary/Related Market Analysis
3.2 Market Segmentation and Scope
3.3 Penetration and Growth Prospect Mapping, Instruments, 2020
3.4 Company Market Share Analysis
3.4.1 Company Size
3.4.2 Geographical presence
3.4.3 Product portfolio
3.4.4 Strategic Initiatives
3.5 Volume Analysis
3.6 Spatial Omics Market: SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.7 Industry Porter’s Analysis
3.8 Market Dynamics
3.8.1 Market Driver Analysis
3.8.1.1 Emerging potential of spatial omic analysis as cancer diagnostic tool
3.8.1.2 Advent of the fourth generation of sequencing (in situ sequencing)
3.8.1.3 Emerging players are expected to boost market competitiveness
3.8.2 Market Restraint Analysis
3.8.2.1 Slow implementation of technology
3.8.2.2 Well-established workflows for conventional omic analysis
3.8.3 Opportunity analysis
3.8.3.1 Gradual adoption of single-cell sequencing
3.8.3.2 Introduction of novel platforms and technologies for MULTI-OMIC studies
3.8.4 Market challenge analysis
3.8.4.1 Challenges pertaining to the single-cell transcriptomics
3.9 COVID-19 Impact Analysis
3.9.1 Impact on supply chain
3.9.2 Recent developments in the market
3.10 Market Deals & Strategic Alliances Analysis
3.10.1 Product Development
3.10.2 Mergers & acquisitions
3.10.3 Technology collaborations
Chapter 4 Technology Business Analysis
4.1 Market: Technology Movement Analysis
4.2 Spatial Proteomics
4.2.1 Market estimates and forecast for Spatial Proteomics, 2017 - 2028 (USD Million)
4.2.2 Imaging Techniques
4.2.2.1 Market estimates and forecast, 2017 - 2028 (USD Million)
4.2.2.2 Microscopy
4.2.2.2.1 Market estimates and forecast, 2017 - 2028 (USD Million)
4.2.2.3 Multiplexed Ion Beam Imaging
4.2.2.3.1 Market estimates and forecast, 2017 - 2028 (USD Million)
4.2.3 Mass Spectrometry
4.2.3.1 Market estimates and forecast, 2017 - 2028 (USD Million)
4.2.4 Immunofluorescence Techniques
4.2.5 Market estimates and forecast, 2017 - 2028 (USD Million)
4.2.6 Centrifugation Techniques
4.2.7 Market estimates and forecast, 2017 - 2028 (USD Million)
4.2.8 Others
4.2.9 Market estimates and forecast, 2017 - 2028 (USD Million)
4.3 Spatial Transcriptomics
4.3.1 Market, 2017 - 2028 (USD Million)
4.3.2 Sequencing-based methods
4.3.2.1 Market for spatial transcriptomics, 2017 - 2028 (USD Million)
4.3.2.2 Laser Capture Microdissection (LCM)
4.3.2.2.1 Market for spatial transcriptomics, 2017 - 2028 (USD Million)
4.3.2.2.2 LCM using FFPE tissue samples
4.3.2.2.2.1 Market for spatial transcriptomics, 2017 - 2028 (USD Million)
4.3.2.2.3 LCM using other tissue samples
4.3.2.2.3.1 Market for spatial transcriptomics, 2017 - 2028 (USD Million)
4.3.2.3 Transcriptome In-vivo Analysis (TIVA)
4.3.2.3.1 Market for spatial transcriptomics, 2017 - 2028 (USD Million)
4.3.2.4 In situ sequencing
4.3.2.4.1 Analysis on spatial resolution, high multiplexing of RNA and protein expression using NGS readout on slide-mounted FFPE
4.3.2.4.2 Market for spatial transcriptomics, 2017 - 2028 (USD Million)
4.3.2.5 Microtomy sequencing
4.3.2.5.1 Market for spatial transcriptomics, 2017 - 2028 (USD Million)
4.3.3 IHC
4.3.3.1 Market for spatial transcriptomics, 2017 - 2028 (USD Million)
4.3.4 Microscopy-based RNA imaging techniques
4.3.4.1 Market for spatial transcriptomics, 2017 - 2028 (USD Million)
4.3.4.2 Single molecule RNA Fluorescence In-situ Hybridization (smFISH)
4.3.4.2.1 Market for spatial transcriptomics, 2017 - 2028 (USD Million)
4.3.4.3 Padlock probes/ Rolling circle amplification
4.3.4.3.1 Market for spatial transcriptomics, 2017 - 2028 (USD Million)
4.3.4.4 Branched DNA probes
4.3.4.4.1 Market for spatial transcriptomics, 2017 - 2028 (USD Million)
4.4 Spatial Genomics
4.4.1 Market, 2017 - 2028 (USD Million)
4.4.2 FISH
4.4.2.1 Market for spatial genomics, 2017 - 2028 (USD Million)
4.4.3 Microscopy-based live DNA imaging
4.4.3.1 Market for spatial genomics, 2017 - 2028 (USD Million)
4.4.4 Genome perturbation tools
4.4.4.1 Market for spatial genomics, 2017 - 2028 (USD Million)
4.4.5 Massively-parallel sequencing
4.4.5.1 Market for spatial genomics, 2017 - 2028 (USD Million)
4.4.6 Biochemical techniques
4.4.6.1 Market for spatial genomics, 2017 - 2028 (USD Million)
4.4.7 Others
4.4.7.1 Market for spatial genomics, 2017 - 2028 (USD Million)
Chapter 5 Product Business Analysis
5.1 Market: Product Movement Analysis
5.2 Instruments
5.2.1 Market for spatial OMICS, 2017 - 2028 (USD Million)
5.2.2 By mode
5.2.2.1 Automated
5.2.2.1.1 Market for spatial OMICS, 2017 - 2028 (USD Million)
5.2.2.2 Semi-automated
5.2.2.2.1 Market for spatial OMICS, 2017 - 2028 (USD Million)
5.2.2.3 Manual
5.2.2.3.1 Market for spatial OMICS, 2017 - 2028 (USD Million)
5.2.3 By type
5.2.3.1 Sequencing platforms
5.2.3.1.1 Market for spatial OMICS, 2017 - 2028 (USD Million)
5.2.3.2 IHC
5.2.3.2.1 Market for spatial OMICS, 2017 - 2028 (USD Million)
5.2.3.3 Microscopy
5.2.3.3.1 Market for spatial OMICS, 2017 - 2028 (USD Million)
5.2.3.4 Flow cytometry
5.2.3.4.1 Market for spatial OMICS, 2017 - 2028 (USD Million)
5.2.3.5 Mass spectrometry
5.2.3.5.1 Market for spatial OMICS, 2017 - 2028 (USD Million)
5.2.3.6 Others
5.2.3.6.1 Market for spatial OMICS, 2017 - 2028 (USD Million)
5.3 Consumables
5.3.1 Market for spatial OMICS, 2017 - 2028 (USD Million)
5.4 Software
5.4.1 Market for spatial OMICS, 2017 - 2028 (USD Million)
5.4.2 Bioinformatics tools
5.4.2.1 Market for spatial OMICS, 2017 - 2028 (USD Million)
5.4.3 Imaging tools
5.4.3.1 Market for spatial OMICS, 2017 - 2028 (USD Million)
5.4.4 Storage and management databases
5.4.4.1 Market for spatial OMICS, 2017 - 2028 (USD Million)
Chapter 6 Workflow Business Analysis
6.1 Market: Workflow Movement Analysis
6.2 Sample Preparation
6.2.1 Market estimates and forecast for Sample Preparation, 2017 - 2028 (USD Million)
6.3 Instrumental Analysis
6.3.1 Market estimates and forecast for Instrumental Analysis, 2017 - 2028 (USD Million)
6.4 Data Analysis
6.4.1 Market estimates and forecast for Data Analysis, 2017 - 2028 (USD Million)
Chapter 7 Sample Type Business Analysis
7.1 Market: Sample Type Movement Analysis
7.2 FFPE
7.2.1 Market estimates and forecast for FFPE Sample type, 2017 - 2028 (USD Million)
7.3 Fresh Frozen
7.3.1 Market estimates and forecast for Fresh Frozen sample type, 2017 - 2028 (USD Million)
Chapter 8 End-Use Business Analysis
8.1 Market: End-use Movement Analysis
8.2 Academic & Translational Research Institutes
8.2.1 Applications of spatial OMICS in academic and translational research
8.2.2 spatial OMICS market for Academic & Translational Research Institutes, 2017 - 2028 (USD Million)
8.3 Pharmaceutical and Biotechnology Companies
8.3.1 Applications of spatial OMICS in pharma & Biotechnology
8.3.2 Market for pharma & biotechnology companies, 2017 - 2028 (USD Million)
Chapter 9 Regional Business Analysis
9.1 Market Share by Regional, 2020 & 2028
9.2 North America
9.2.1 North America Spatial OMICS market estimates and forecast, 2017 - 2028 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.2.2.2 U.S. spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.2.2.3 U.S. spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.2.2.4 U.S. spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.2.2.5 U.S. spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
9.2.3 Canada
9.2.3.1 Canada spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.2.3.2 Canada spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.2.3.3 Canada spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.2.3.4 Canada spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.2.3.5 Canada spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
9.3 Europe
9.3.1 Europe Spatial OMICS market estimates and forecast, 2017 - 2028 (USD Million)
9.3.2 Germany
9.3.2.1 Germany spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.3.2.2 Germany spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.3.2.3 Germany spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.3.2.4 Germany spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.3.2.5 Germany spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
9.3.3 U.K.
9.3.3.1 U.K. spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.3.3.2 U.K. spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.3.3.3 U.K. spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.3.3.4 U.K. spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.3.3.5 U.K. spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
9.3.4 France
9.3.4.1 France spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.3.4.2 France spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.3.4.3 France spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.3.4.4 France spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.3.4.5 France spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
9.3.5 Italy
9.3.5.1 Italy spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.3.5.2 Italy spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.3.5.3 Italy spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.3.5.4 Italy spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.3.5.5 Italy spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
9.3.6 Spain
9.3.6.1 Spain spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.3.6.2 Spain spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.3.6.3 Spain spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.3.6.4 Spain spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.3.6.5 Spain spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
9.3.7 Netherlands
9.3.7.1 Netherlands spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.3.7.2 Netherlands spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.3.7.3 Netherlands spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.3.7.4 Netherlands spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.3.7.5 Netherlands spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific Spatial OMICS market estimates and forecast, 2017 - 2028 (USD Million)
9.4.2 Japan
9.4.2.1 Japan spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.4.2.2 Japan spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.4.2.3 Japan spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.4.2.4 Japan spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.4.2.5 Japan spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
9.4.3 China
9.4.3.1 China spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.4.3.2 China spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.4.3.3 China spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.4.3.4 China spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.4.3.5 China spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
9.4.4 India
9.4.4.1 India spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.4.4.2 India spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.4.4.3 India spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.4.4.4 India spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.4.4.5 India spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
9.4.5 South Korea
9.4.5.1 South Korea spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.4.5.2 South Korea spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.4.5.3 South Korea spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.4.5.4 South Korea spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.4.5.5 South Korea spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
9.4.6 Australia
9.4.6.1 Australia spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.4.6.2 Australia spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.4.6.3 Australia spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.4.6.4 Australia spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.4.6.5 Australia spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
9.4.7 Singapore
9.4.7.1 Singapore spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.4.7.2 Singapore spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.4.7.3 Singapore spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.4.7.4 Singapore spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.4.7.5 Singapore spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
9.5 Latin America
9.5.1 Latin America Spatial OMICS market estimates and forecast, 2017 - 2028 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.5.2.2 Brazil spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.5.2.3 Brazil spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.5.2.4 Brazil spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.5.2.5 Brazil spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
9.6 Middle East and Africa (MEA)
9.6.1 MEA Spatial OMICS market estimates and forecast, 2017 - 2028 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa spatial OMICS market, by technology, 2017 - 2028 (USD Million)
9.6.2.2 South Africa spatial OMICS market, by product, 2017 - 2028 (USD Million)
9.6.2.3 South Africa spatial OMICS market, by workflow, 2017 - 2028 (USD Million)
9.6.2.4 South Africa spatial OMICS market, by sample type, 2017 - 2028 (USD Million)
9.6.2.5 South Africa spatial OMICS market, by end-use, 2017 - 2028 (USD Million)
Chapter 10 Competitive Landscape
10.1 Strategy Framework
10.2 Market Participation Categorization
10.3 Company Profiles
10.3.1 10x Genomics
10.3.1.1 Company overview
10.3.1.1.1 SPATIAL TRANSCRIPTOMICS
10.3.1.1.2 CARTANA AB
10.3.1.1.3 READCOOR, INC.
10.3.1.2 Financial Performance
10.3.1.2.1 Financial Performance: CARTANA AB
10.3.1.3 Product benchmarking
10.3.1.4 Strategic initiatives
10.3.2 Dovetail Genomics
10.3.2.1 Company overview
10.3.2.2 Financial Performance
10.3.2.3 Product benchmarking
10.3.2.4 Strategic initiatives
10.3.3 S2 Genomics, Inc.
10.3.3.1 Company overview
10.3.3.2 Financial Performance
10.3.3.3 Product benchmarking
10.3.3.4 Strategic initiatives
10.3.4 NanoString Technologies, Inc.
10.3.4.1 Company overview
10.3.4.2 Financial Performance
10.3.4.3 Product benchmarking
10.3.4.4 Strategic initiatives
10.3.5 Seven Bridges Genomics
10.3.5.1 Company overview
10.3.5.2 Financial Performance
10.3.5.3 Product benchmarking
10.3.5.4 Strategic initiatives (Beckman Coulter)
10.3.7 PerkinElmer, Inc.
10.3.7.1 Company overview
10.3.7.1.1 Horizon Discovery Group plc
10.3.7.2 Financial Performance
10.3.7.2.1 Financial Performance: Horizon Discovery Group Plc
10.3.7.3 Product benchmarking
10.3.7.4 Strategic initiatives
10.3.8 Bio-Techne
10.3.8.1 Company overview
10.3.8.1.1 Advanced Cell Diagnostics, Inc. (ACD)
10.3.8.2 Financial Performance
10.3.8.2.1 Financial Performance: ACD
10.3.8.3 Product benchmarking
10.3.8.4 Strategic initiatives
10.3.9 Danaher Corporation
10.3.9.1 Company overview
10.3.9.1.1 Leica Biosystems Nussloch GmbH
10.3.9.2 Financial Performance
10.3.9.2.1 Financial performance (Leica Biosystems Nussloch GmbH)
10.3.9.3 Product benchmarking
10.3.9.4 Strategic initiatives
10.3.10 IonPath, Inc.
10.3.10.1 Company overview
10.3.10.2 Financial Performance
10.3.10.3 Product benchmarking
10.3.10.4 Strategic initiatives
10.3.11 Millennium Science Pty Ltd.
10.3.11.1 Company overview
10.3.11.2 Financial Performance
10.3.11.3 Product benchmarking
10.3.12 Akoya Biosciences, Inc.
10.3.12.1 Company overview
10.3.12.2 FINANCIAL Performance
10.3.12.3 Product benchmarking
10.3.12.4 Strategic initiatives
10.3.13 Fluidigm Corporation
10.3.13.1 Company overview
10.3.13.2 Financial Performance
10.3.13.3 Product benchmarking
10.3.13.4 Strategic initiatives
10.3.14 Diagenode Diagnostics
10.3.14.1 Company overview
10.3.14.2 Financial Performance
10.3.14.3 Product benchmarking
10.3.15 Biognosys AG
10.3.15.1 Company overview
10.3.15.2 Financial Performance
10.3.15.3 Product benchmarking
10.3.15.4 Strategic initiatives
10.3.16 Rebus Biosystems
10.3.16.1 Company overview
10.3.16.2 Product benchmarking
10.3.16.3 Strategic initiatives
10.3.17 Ultivue, Inc.
10.3.17.1 Company overview
10.3.17.2 Product benchmarking
10.3.17.3 Strategic initiatives
10.3.18 Vizgen Corp.
10.3.18.1 Company overview
10.3.18.2 Product benchmarking
10.3.18.3 Strategic initiatives
10.3.19 BioSpyder Technologies
10.3.19.1 Company overview
10.3.19.2 Financial Performance
10.3.19.3 Product benchmarking
10.3.20 Bruker
10.3.20.1 Company overview
10.3.20.1.1 Acuity Spatial Genomics, Inc.
10.3.20.2 Financial Performance
10.3.20.3 Product benchmarking
10.3.20.4 Strategic initiatives
10.3.21 Brooks Automation, Inc.
10.3.21.1 Company overview
10.3.21.1.1 GENEWIZ
10.3.21.2 Financial Performance
10.3.21.2.1 Financial Performance: Genewiz
10.3.21.3 Product benchmarking
10.3.21.4 Strategic initiatives
